Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Sensient Cosmetic Technologies focuses its patent filings in the Biotechnology & Pharmaceuticals technology area. The company currently has 1 pending office action that requires a formal response. This workload is handled by 1 distinct examiner, which indicates a singular focus for the current prosecution efforts. Furthermore, the active matter is situated within 1 distinct art unit, ensuring that the technical review is conducted by a specialized group within the patent office.
The busiest examiner for this portfolio is ALAWADI, SARAH, who is responsible for 1 busiest examiner pending office action. Because the total number of pending office actions is 1, this examiner is currently managing the whole of the company's active prosecution. Practitioners should analyze the specific examination patterns of ALAWADI, SARAH to better prepare for potential hurdles in the Biotechnology & Pharmaceuticals sector. The presence of 1 distinct examiner and 1 distinct art unit allows for a streamlined approach to prosecution without the complexity of coordinating across different technical departments.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALAWADI, SARAH | 1 | 37.5% | +38.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18554422 | WHITENING COMPOSITION USEFUL FOR THE PREPARATION OF COSMETIC FORMULATIONS | ALAWADI, SARAH | 40d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18554422 | WHITENING COMPOSITION USEFUL FOR THE PREPARATION OF COSMETIC FORMULATIONS | ALAWADI, SARAH | 40d |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18554422 | WHITENING COMPOSITION USEFUL FOR THE PREPARATION OF COSMETIC FORMULATIONS | ALAWADI, SARAH | 1619 | §102§103 | Non-Final OA | 40d | Pending | Oct 06, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial